Literature DB >> 19183943

Modeling the effect of time-dependent exposure on intensive care unit mortality.

Martin Wolkewitz1, Jan Beyersmann, Petra Gastmeier, Martin Schumacher.   

Abstract

PURPOSE: To illustrate modern survival models with focus on the temporal dynamics of intensive care data. A typical situation is given in which time-dependent exposures and competing events are present.
METHODS: We briefly review the following established statistical methods: logistic regression, regression models for event-specific hazards and the subdistribution hazard. These approaches are compared by showing advantages as well as disadvantages. All methods are applied to real data from a study of day-by-day ICU surveillance.
RESULTS: Standard logistic regression ignores the time-dependent nature of the data and is only a crude approach. Cumulative hazards and probability plots add important information and provide a deep insight into the temporal dynamics.
CONCLUSION: This paper might help to encourage researchers working in hospital epidemiology to apply adequate statistical models to complex medical questions.

Mesh:

Year:  2009        PMID: 19183943     DOI: 10.1007/s00134-009-1423-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  28 in total

Review 1.  Logistic or Cox model to identify risk factors of nosocomial infection: still a controversial issue.

Authors:  S Chevret
Journal:  Intensive Care Med       Date:  2001-10       Impact factor: 17.440

2.  Comparison of different methodological approaches to identify risk factors of nosocomial infection in intensive care units.

Authors:  J de Irala-Estévez; D Martínez-Concha; C Díaz-Molina; J Masa-Calles; A Serrano del Castillo; R Fernández-Crehuet Navajas
Journal:  Intensive Care Med       Date:  2001-08       Impact factor: 17.440

3.  Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.

Authors:  Andrew F Shorr; Alain Combes; Marin H Kollef; Jean Chastre
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

4.  Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events.

Authors:  G Schulgen; A Kropec; I Kappstein; F Daschner; M Schumacher
Journal:  J Clin Epidemiol       Date:  2000-04       Impact factor: 6.437

5.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

6.  Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs.

Authors:  Xiaoyan Song; Arjun Srinivasan; David Plaut; Trish M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2003-04       Impact factor: 3.254

7.  The impact of antimicrobial resistance on health and economic outcomes.

Authors:  Sara E Cosgrove; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2003-05-16       Impact factor: 9.079

8.  Attributable mortality due to nosocomial infections. A simple and useful application of multistate models.

Authors:  M Schumacher; M Wangler; M Wolkewitz; J Beyersmann
Journal:  Methods Inf Med       Date:  2007       Impact factor: 2.176

9.  Regression modelling in hospital epidemiology: a statistical note.

Authors:  Martin Wolkewitz; Jan Beyersmann; Petra Gastmeier; Martin Schumacher
Journal:  Crit Care       Date:  2008-09-04       Impact factor: 9.097

Review 10.  Year in review in Intensive Care Medicine, 2006. II. Infections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard
Journal:  Intensive Care Med       Date:  2007-01-13       Impact factor: 17.440

View more
  15 in total

1.  Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models.

Authors:  Molière Nguile-Makao; Jean-Ralph Zahar; Adrien Français; Alexis Tabah; Maité Garrouste-Orgeas; Bernard Allaouchiche; Dany Goldgran-Toledano; Elie Azoulay; Christophe Adrie; Samir Jamali; Christophe Clec'h; Bertrand Souweine; Jean-Francois Timsit
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

2.  A note on statistical association and causality derived from epidemiological ICU data.

Authors:  Martin Wolkewitz; Jan Beyersmann; Martin Schumacher
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

3.  Incidence in ICU populations: how to measure and report it?

Authors:  Jan Beyersmann; Petra Gastmeier; Martin Schumacher
Journal:  Intensive Care Med       Date:  2014-05-10       Impact factor: 17.440

4.  Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections.

Authors:  Marlieke E A de Kraker; Martin Wolkewitz; Peter G Davey; Walter Koller; Jutta Berger; Jan Nagler; Claudine Icket; Smilja Kalenic; Jasminka Horvatic; Harald Seifert; Achim J Kaasch; Olga Paniara; Athina Argyropoulou; Maria Bompola; Edmond Smyth; Mairead Skally; Annibale Raglio; Uga Dumpis; Agita Melbarde Kelmere; Michael Borg; Deborah Xuereb; Mihaela C Ghita; Michelle Noble; Jana Kolman; Stanko Grabljevec; David Turner; Louise Lansbury; Hajo Grundmann
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

Review 5.  Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-08       Impact factor: 17.440

6.  Adjusting for time-varying confounding in the subdistribution analysis of a competing risk.

Authors:  Maarten Bekaert; Stijn Vansteelandt; Karl Mertens
Journal:  Lifetime Data Anal       Date:  2009-10-10       Impact factor: 1.588

7.  How to handle mortality when investigating length of hospital stay and time to clinical stability.

Authors:  Guy N Brock; Christopher Barnes; Julio A Ramirez; John Myers
Journal:  BMC Med Res Methodol       Date:  2011-10-26       Impact factor: 4.615

8.  Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis.

Authors:  Christophe Clec'h; Frédéric Gonzalez; Alexandre Lautrette; Molière Nguile-Makao; Maïté Garrouste-Orgeas; Samir Jamali; Dany Golgran-Toledano; Adrien Descorps-Declere; Frank Chemouni; Rebecca Hamidfar-Roy; Elie Azoulay; Jean-François Timsit
Journal:  Crit Care       Date:  2011-05-17       Impact factor: 9.097

9.  Mortality review as a tool to assess the contribution of healthcare-associated infections to death: results of a multicentre validity and reproducibility study, 11 European Union countries, 2017 to 2018.

Authors:  Tjallie van der Kooi; Alain Lepape; Pascal Astagneau; Carl Suetens; Mioara Alina Nicolaie; Sabine de Greeff; Ilma Lozoraitiene; Jacek Czepiel; Márta Patyi; Diamantis Plachouras
Journal:  Euro Surveill       Date:  2021-06

10.  Outcome of ICU patients with Clostridium difficile infection.

Authors:  Jean-Ralph Zahar; Carole Schwebel; Christophe Adrie; Maité Garrouste-Orgeas; Adrien Français; Aurélien Vesin; Molière Nguile-Makao; Alexis Tabah; Kevin Laupland; Alban Le-Monnier; Jean-François Timsit
Journal:  Crit Care       Date:  2012-11-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.